Table 1.

Baseline characteristics of study patients

Characteristics	Event group (n = 36)	Control group (n = 55)	P values
Age , years, mean (standard deviation)a	53.5 (13.8)	54.4 (13.1)	0.759
Male sex, n (%)	29 (81)	46 (84)	0.781
Race, n (%)
Caucasian	34 (94)	54 (98)	0.560
Other	2 (6)	1 (2)	0.560
Indication for cardiac transplantation, n (%)
Coronary Artery Disease	15 (42)	18 (33)	0.504
Idiopathic Cardiomyopathy	14 (39)	30 (55)	0.198
Valvular Heart Disease	2 (6)	3 (5)	1.000
Acute Myocarditis	1 (3)	2 (4)	1.000
Congenital Heart Disease	1 (3)	0 (0)	0.396
Other indications	3 (8)	3 (4)	0.381
Use of ventricular assist device before transplantation, n (%)	6 (17)	13 (24)	0.599
Induction therapy (any), n (%)	28 (79)	45 (82)	0.784
Cytomegalovirus serology (IgG) status, n (%)
Donor and Recipient Positive	13 (36)	13 (24)	0.239
Donor and Recipient Negative	7 (19)	9 (16)	0.781
Donor Positive and Recipient Negative	3 (8)	6 (11)	1.000
Donor Negative and Recipient Positive	6 (17)	14 (25)	0.439
Unknown	7 (19)	13 (24)	0.797

P values were calculated using two-tailed Fisher’s exact test unless indicated otherwise

^aTwo-sample t-test